Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02225496 · ClinicalTrials.gov registry record · Phase 2
Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02225496: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT02225496 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02225496, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Standard-of-care treatment options for oropharyngeal cancer often result in long-term side effects that interfere with normal quality of life. A minimally-invasive transoral robotic surgery (TORS) approach has been developed to operate on the disease site while affecting the surrounding tissue as little as possible. Researchers think that this approach may help to control the disease and avoid such long-term side effects. The goal of this clinical research study is to learn if minimally-invasive transoral robotic surgery (TORS) can help to control HPV-positive oropharyngeal cancer. Transoral means through the mouth. The TORS approach is called the Intuitive Surgical da Vinci Surgical System. Researchers also want to learn if this surgery affects participants' ability to speak and swallow.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Modified Barium Swallow (MBS)
- PROCEDURE Transoral Robotic Surgery (TORS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-09-23 |
| Est. Completion | 2017-12-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02225496
The ClinicalTrials.gov registry entry for NCT02225496 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT02225496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02225496 about?
NCT02225496 is a clinical study titled "Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma". Standard-of-care treatment options for oropharyngeal cancer often result in long-term side effects that interfere with normal quality of life. A minimally-invasive transoral robotic surgery (TORS) approach has been developed to operate on the disease site while affecting the surrounding tissue as li...
What is the current status of trial NCT02225496?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2014-09-23. Estimated completion is 2017-12-08.
What interventions are being tested in trial NCT02225496?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Modified Barium Swallow (MBS) (PROCEDURE), Transoral Robotic Surgery (TORS) (PROCEDURE).
Who is sponsoring clinical trial NCT02225496?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.